Medicine - Xagena

Medicine

News

Drugs

Xapedia

Farmaci

Farmacia

Medicina

Specialità

Warfarin increases risk of bone fracture

Angiopoietin-2, a new player in sepsis-associated acute respiratory distress syndrome

Major cardiovascular damage: modified troponin I protein improves heart function

Coronary artery disease: Rosuvastatin may reverse atherosclerosis

Trauma to the aorta causes cognitive loss following coronary artery bypass surgery

Protein MDC1 amplifies DNA injury signals

CBFB-SMMHC, an oncoprotein, induces abnormal preleukemic blood cell progenitors

Urine test helps detect 99 percent of recurring bladder cancers

Bexarotene is a potential lung cancer preventative with few side effects

HPV DNA testing is a cost-effective strategy for women with equivocal cervical screening results

Study CAPRIE: Moxifloxacin more effective at treating elders' pneumonia

Fitness counteracts cognitive decline from hormone-replacement therapy

Genetically modified lactic acid bacteria to prevent HIV infection

Gardasil, a new vaccine for prevention of cervical cancer in females caused by human papillomavirus

Spinocerebellar ataxia type 5 caused by mutations in the protein beta-III spectrin

Technique for multiplying adult stem cells developed

Malaria parasites develop in lymph nodes

Genetic predisposition may raise risk of Emanuel syndrome

NovoSeven for intracerebral hemorrhage: a promising therapy

HIV/AIDS trial: continuous antiretroviral therapy superior to episodic therapy

Map of part of adult human brain containing astrocytes released

K-Ras can be manipulated to promote cell death

Farnesyltransferase inhibitor may improve progeria

Sensible metabolic differences in how adults, infants and children process drugs

Rad9 as a potential target for cancer therapy

Bismacine may cause serious adverse events

Wine drinkers have healthier diets than beer drinkers

CDK4 as a targeted approach to treating aggressive breast cancers

Wet age-related macular degeneration: FDA has approved Lucentis

HIV-1 infection: FDA has approved Atripla, an once-a-day three-drug combination

Fingolimod: sustained efficacy over 18 months in patients with relapsing multiple sclerosis

Botox as an adjuvant to cancer therapy

Healthy preterm infants show reduced lung function

Smokers: supplements of vitamin C can stop the serious depletion of vitamin E

New test could help in diagnosing shaken baby syndrome

Ovarian cancer responds to Aspirin derivative with Cisplatin

WHI: a small but significant 1 percent higher hip bone density for women taking calcium combined with vitamin D

tPA-ultrasound combination increases reopening of blocked arteries after stroke

Training benefits brains in older people

FDA has approved Sprycel in chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia, with resistance to prior therapy

Huntington's disease: Tetrabenazine may cut down involuntary movements

Calcium and Vitamin D slightly decrease risk of hip fractures in older women

Omega-3 fatty acids are unlikely to reduce the risk of cancer

Carbon monoxide poisoning: heart injury increases long-term risk of death

Parkinson’s disease: Exelon for treatment of dementia

Wet age-related macular degeneration: FDA has approved Lucentis

Bipolar disorder in children and teens is different from adults

Levitra may protect the heart following acute myocardial infarction

Mangafodipir may improve cancer-killing ability of chemotherapy

Antioxidant supplementation not associated with decreased risk of prostate cancer

Morphine and topical Tetracaine found effective in treating pain in newborn infants

Tetrabenazine is effective to treat the excessive involuntary movements of Huntington’s

A study finds four in 10 myocardial infarctions go unrecognised

Non-BRCA hereditary breast cancer linked to new cancers

X chromosome abnormalities contribute to the pathogenesis of basal-like breast cancers

Small molecules overcome drug resistance in cancers associated with high-risk viruses

Diuretics reduce risk of death from congestive heart failure

Major depression, electroconvulsive therapy improves quality of life for at least six months

Stroke, few patients get to hospital in time for treatment

Asthma, older adult patients have increased cancer risk

Thrombolitic therapy before angioplasty or stent placement not beneficial for myocardial infarction patients

Infectious agents pose new risks for people with bleeding disorders

Safety and efficacy of Risedronate for the treatment of male osteoporosis

Seasonal affective disorder: FDA has approved Wellbutrin XL

Advanced cervical cancer: FDA has approved a combination of Hycamtin and Cisplatin

NICE recommends Herceptin for early breast cancer

Multiple sclerosis: BG-12 reduces number of gadolinium-enhancing brain lesions

Combination of Vildagliptin and Pioglitazone in patients with type 2 diabetes

Exenatide: sustained improvements in blood glucose control and progressive weight loss after two years

Gardasil for prevention of cervical cancer and other diseases in females caused by HPV

Type 2 diabetes, Sitagliptin reduces blood glucose levels in monotherapy or as add-on treatment

Ruboxistaurin reduces the risk of vision loss caused by diabetic retinopathy

Acetylsalicylic Acid reduces cardiovascular risks in men and women, but differently

Variations in growth-factor gene linked to risk of prostate cancer

Alzheimer's disease linked to abnormal cell division

Tenecteplase-facilitated PCI in patients with ST-segment elevation acute myocardial infarction is not recommended

Relapsing multiple sclerosis: FDA has approved the reintroduction of Tysabri

Antitumor activity of Panitumumab in metastatic colorectal cancer

Vorinostat in patients with advanced, refractory cutaneous T-cell lymphoma

Chemotherapy-induced anemia: benefits of Aranesp with intravenous Iron

Better survival seen for early breast cancer patients switched from Tamoxifen to Exemestane

Advanced breast cancer: Tykerb an alternative to Herceptin

Evista associated with increased risk of stroke mortality in postmenopausal women at increased risk for cardiovascular disease

Advanced HER2-positive breast cancer: Herceptin added to hormonal therapy prolongs progression-free survival

EU: Herceptin for early-stage in HER2-positive breast cancer approved

p11 appears to help regulate signaling of the brain messenger chemical serotonin

How one disease may prevent another

Treating periodontal disease may reduce the risk of cardiovascular disease

Azilect, a new treatment for Parkinson's Disease

Blood test can predict long-term risk of death in patients with shortness of breath

Low-carbohydrate diets appear effective, but may raise cholesterol levels

Tumor size related to lung cancer spread

Estrogen therapy does not appear to protect postmenopausal women from heart disease

Pyridostigmine appears to improve standing blood pressure in patients with orthostatic hypotension

Glaucoma patients appear to have increased eye pressure during sleep

For men with cardiovascular disease, there is apparently no normal glucose level

Adalimumab for maintaining clinical remission in patients with Crohn's disease

Basic research at the Max Planck Institute of Biochemistry leads to a novel cancer therapy

Neurodegenerative disease: mechanism that causes cell death

Neuronal receptor response may help explain Alzheimer's memory loss

Pagine successive « [11] 12 13 14 15 16 17 18 19 20 »

Link

Specialità

Patologie

Patologie

© XAGENA 2010 - P.IVA: 04454930969 - REA: 1748680 - Tutti i diritti riservati